RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Morningside
M

Morningside portfolio

Morningside has 14 portfolio companies on record at Recent Funding, with 3 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 14.
Deals, last 12 months: 3.
Rounds led: 4 of 15.
Capital in their rounds: $1.17B.
Latest deal: Sleptay · Sep 28, 2026.
About this page

It led 4 of the 15 rounds it joined. Its most recent investment on record is Sleptay's Series A round in September 2026, alongside Qianju Capital, Shunwei Capital, Decheng Capital and 2 others. By category, its portfolio leans toward Health and bio (10) and Commerce and retail (2). It has co-invested with Sanofi Ventures, Abingworth and SymBiosis, most often Sanofi Ventures (2 rounds).

What Morningside invests in

Morningside recent investments

CompanyRoundDateAlongside
SSleptaySeries AQianju Capital, Shunwei Capital, Decheng Capital (lead) +2
AAdvanCellSeries B+ · $315MFidelity Management & Research Company, Eli Lilly, Abingworth +15
AAngitia BioSeries B+ · $130MVenrock Healthcare Capital Partners (lead), Wellington Management, TF Capital +6
AAdvanCellSeries B+ · $112MAbingworth (lead), SymBiosis (lead), Brandon Capital +3
GGeneoscopySeries B+ · $105MVaria Ventures, Granger Management LLC, NT Investments +6
AAngitia BioSeries B+ · leadElikon Venture, Oriza Holdings, OrbiMed +4
AAdvanCellSeries B+ · $12.5M · leadnone named
BBeviSeries B+ · $70MCowen Group (lead), Bessemer Venture Partners

How Morningside invests

StageDealsCapital in rounds
Series B+ 13 87%$1.13B
Series A 2 13%$40M
YearDealsCapital in rounds
2020 2 13%$82M
2021 4 27%$268M
2022 3 20%$157.5M
2023 1 7%undisclosed
2025 2 13%$217M
2026 3 20%$445M

Morningside portfolio companies

CompanyRound with MorningsideTotal raisedLatest raise
SSleptay
Health and bio
Series AundisclosedSep 28, 2026
Series A
AAdvanCell
Health and bio
Series B+ · $315M$439.5MJul 15, 2026
Series B+
AAngitia Bio
Health and bio
Series B+ · $130M$130MFeb 12, 2026
Series B+
GGeneoscopy
Health and bio
Series B+ · $105M$216.9MJan 8, 2025
Series B+
BBevi
Robotics and hardware
Series B+ · $70M$128MAug 11, 2022
Series B+
BBig Health
Health and bio
Series B+ · $75M$129.3MJan 19, 2022
Series B+
DDeepCure
Health and bio
Series A · $40M · lead$64MApr 11, 2024
Series A
EExo Therapeutics
Health and bio
Series B+ · $78M$103MOct 5, 2021
Series B+
PPhoreMost
Health and bio
Series B+ · $45M$72MSep 10, 2024
Series B+
ZZilliz
Data and analytics
Series B+ · $43M$103MAug 24, 2022
Series B+
LLeague
Health and bio
backer$66MJul 24, 2018
Series B+
BBetterUp
HR and recruiting
backer$6MOct 22, 2025
Seed
FF2G
Health and bio
backer$100MSep 12, 2024
Series B+
SSharebite
Commerce and retail
backer$54MJun 28, 2022
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 15 rounds on Recent Funding that name Morningside. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Morningside, which is a subset of its real portfolio. API: /api/v1/investors/morningside (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy